Publication: 2946

Publication: 2946

A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Clin Pharmacol Ther vol 105 (3) 738-745

Year:: 2019
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pmc-release

Note:

Methodological:: Yes
Biospecimen:: No
SDC:: No
Book Volume:: 8

Parents:: None
Children:: None

Program:: TRP
Primary Committee:: PPP
Sec. Committees:: Breast

Pharmas:: Celgene, BMS
Grants:: U10CA180821, U10CA180882, U10CA180833, U24CA19617, U10CA180836, U10CA180838, U10CA180867

Corr. Author:
Authors:: Sara R. Rashkin Katherina C. Chua Carol Ho Flora Mulkey Chen Jiang Tasei Mushiroda Michiaki Kubo Paula N. Friedman Hope S. Rugo Howard L. McLeod Mark J. Ratain Francisco Castillos Michael Naughton Beth Overmoyer Deborah Toppmeyer John S. Witte Kouros Owzar Deanna L. Kroetz

Networks:: CA824, DE012, HEARTLAND, LAPS-IL036, LAPS-IL057, LAPS-MA036, SCOR

Study: CALGB-40502
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords:: prediction model, pharmacogenomics, breast cancer, microtubule targeting agents